>> Login
>> New User Registration
March 11, 2010
Co-Chairs

Dr. Bunn
Paul A. Bunn, Jr., MD
James Dudley Chair in Cancer Research
Professor, Medical Oncology
University of Colorado Denver
Aurora, CO
Executive Director, International Association for the Study of Lung Cancer
(IASLC)

Dr. Bunn
Roy S. Herbst, MD, PhD
Chief, Section of Thoracic Oncology
Professor of Medicine & Cancer Biology
Department of Thoracic / Head & Neck Medical Oncology
Co-Director, Phase I Clinical Trials Working Group
The University of Texas
M. D. Anderson Cancer Center
Houston, TX

Dr. Bunn
Corey J. Langer, MD
Professor of Medicine
Director, Thoracic Oncology
Division of Hematology-Oncology
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA
Vice Chair, Radiation Therapy Oncology Group
(RTOG)


Other Expert Faculty


Walter J. Curran, MD, FACR
Professor and Chair
Department of Radiation Oncology
Emory School of Medicine Chief Medical Officer
Winship Cancer Institute
Atlanta, GA
Chairman, Radiation Therapy Oncology Group
(RTOG)


Edward B. Garon, MD
 


Barbara J. Gitlitz, MD
 


Fairooz F. Kabbinavar, MD
 


Mark G. Kris, MD
Chief, Thoracic Oncology Service
William and Joy Ruane Chair in Thoracic Oncology
Memorial Sloan-Kettering Cancer Center
New York, NY


Thomas J. Lynch, MD
Chief, Division of Hematology and Oncology
Director, Center for Thoracic Cancer
Massachusetts General Hospital
Cancer Center
Boston, MA


Ignacio I. Wistuba, MD
 

The Third Annual Symposium on Personalized Therapies and Best Clinical Practices for Lung Cancer and Head and Neck Cancer is under development.

Save the Date: August 28, 2010

Hyatt Regency La Jolla at Aventine
3777 La Jolla Village Drive
San Diego, California, 92122
Tel: +1 858 552 1234

Co-Chairs

Paul A. Bunn, Jr., MD
James Dudley Chair in Cancer Research
Professor, Medical Oncology
University of Colorado Denver
Aurora, CO
Executive Director, International Association for the Study of Lung Cancer
(IASLC)

Roy S. Herbst, MD, PhD
Chief, Section of Thoracic Oncology
Professor of Medicine & Cancer Biology
Department of Thoracic / Head & Neck Medical Oncology
Co-Director, Phase I Clinical Trials Working Group
The University of Texas
M. D. Anderson Cancer Center
Houston, TX

Corey J. Langer, MD
Professor of Medicine
Director, Thoracic Oncology
Division of Hematology-Oncology
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA
Vice Chair, Radiation Therapy Oncology Group
(RTOG)

Taught by the top academic experts in lung cancer and head & neck cancer this is THE symposium on lung cancer and head & neck cancer that you should attend in 2010. It contains the most up-to-date data from the recent ASCO meeting. This symposium will help clinicians improve their selection of the most appropriate therapeutics, and will also help clinicians to identify the patient sub-populations of lung cancer and head & neck cancer who will respond to specific drug therapies.


Hotel Accommodations and Discounted Room Rates Back to Top

Hyatt Regency La Jolla at Aventine
3777 La Jolla Village Drive
San Diego, California, USA 92122
Tel: +1 858 552 1234

Discover the many facets of Hyatt Regency La Jolla at Aventine and enjoy a seaside destination with the charm of a European village and the panache of Southern California. Located in the city known as "The Jewel of the Pacific", our stunning La Jolla hotel offers incomparable beaches, shopping, dining, galleries and attractions. Visit Stephen Birch Aquarium & Museum, spend a day kayaking, take a Baja Lobster or Wine tour, see live theater or shop San Diego's trendy boutiques; all just minutes away.

Educational Grants
Sincere appreciation is extended to the following companies for their generous commercial support of this educational meeting:

OBR
© 2010 Oncology Learning Center
1415 Legacy Drive, Suite 250 • Frisco, TX 75034 • Phone: 214.866.0305 • Fax: 214.866.0311
Disclaimer: The material published on the Oncology Learning Center Web site reflect the opinions and expertise of the authors and/or reviewers of the material, and not the opinions of the Oncology Learning Center, the CME provider, or the pharmaceutical companies providing educational grants. The materials may address uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. Before using any therapeutic approaches reviewed in this material, a qualified medical or surgical oncologist, or hematologist should be consulted. Readers of this content should verify all information and data before treating patients or using any drugs or therapies described in any Oncology Learning Center materials. Click here for our Privacy Policy.